Programseite

Plenary Speakers

Internationally leading scientists in diabetes research are joining us in Munich to present and discuss their most recent data and achievements.

 

Bruce Spiegelman, Dana Farber Cancer Institute

Philipp Scherer, UT Southwestern

Stephen O'Rahilly, University of Cambridge

David Mangelsdorf, UT Southwestern

Jeffrey Friedman, The Rockerfeller University

Michael Lehrke, University Hospital Aachen

Bart Staels, University of Lille

Jens Holst, University of Copenhagen

Sabrian Diano, Columbia University Irving Medical Center

Ruth Gimeno, Eli Lilly and Company

Victoria Parker, Astra Zeneca

Jon Campbell, Duke Molecular Physiology Institute

Domenico Accili, Columbia University

Susan-Bonner Weir, Harvard University

Timo Müller, Helmholtz Munich

Matthew Hayes, University of Pennsylvania

Barbara Kahn, Harvard Medical School